Internal Medicine, Pulmonary Disease · Galloway, NJ
NPI
1760573513
Since 2006
Specialty
Internal Medicine, Pulmonary Disease
Code 207RP1001X
Group practices
1
Medicare group memberships
Hospitals
3
Hospital affiliations
54 W Jimmie Leeds Rd, Suites 4 & 5
Galloway, NJ, 08205
Phone (609) 404-0056
Groups this clinician bills Medicare through
Medicare paid, 2024
$587K
8,044 services
Medicare patients, 2024
901
Average age 74
Drug cost, 2024
$4.4M
4,787 prescriptions
Company payments, 2025
$696
From 6 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Salaam T Alobeidy was code 99215 (office e&m - established), 1,801 times for 628 patients. In total Salaam T Alobeidy billed 8,044 services in 34 codes, and Medicare paid $587K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2023-09-01.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99215 Office E&M - Established | Office | 1,801 | 628 | $142.58 | $257K |
| 99307 SNF E&M | Facility | 921 | 68 | $31.35 | $29K |
| 94010 Pulmonary Function Testing | Office | 848 | 493 | $22.80 | $19K |
| 99233 Hospital E&M - Subsequent | Facility | 831 | 129 | $95.74 | $80K |
| 94726 Pulmonary Function Testing | Office | 726 | 458 | $46.50 | $34K |
| 94729 Pulmonary Function Testing | Office | 725 | 460 | $46.53 | $34K |
| 94618 Pulmonary Function Testing | Office | 430 | 326 | $28.17 | $12K |
| G2212 Prolonged office or other outpatient evaluation and management service(s) beyond the maximum required time of the primary procedure which has been selected using total time on the date of the primary service; each additional 15 minutes by the physician or | Office | 326 | 236 | $26.72 | $8,711 |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 249 | 204 | $13.64 | $3,395 |
| 99443 Telephone Services | Office | 225 | 149 | $78.23 | $18K |
| 99307 SNF E&M | Office | 163 | 32 | $27.40 | $4,467 |
| 99223 Hospital E&M - Initial | Facility | 160 | 134 | $136.80 | $22K |
| 99205 Office E&M - New | Office | 134 | 134 | $176.42 | $24K |
| 95800 Sleep Study | Office | 103 | 98 | $111.19 | $11K |
| 99304 SNF E&M | Facility | 80 | 56 | $65.49 | $5,239 |
By year: 2022 $549K for 5,696 services; 2023 $549K for 6,699 services; 2024 $587K for 8,044 services.
Medicare prescription drug claims, 2024
In 2024, the drug Salaam T Alobeidy prescribed most often to Medicare patients was Trelegy Ellipta (Fluticasone/Umeclidin/Vilanter), with 606 prescriptions and refills. In total Salaam T Alobeidy wrote 4,787 Medicare prescriptions that cost $4.4M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Trelegy Ellipta Fluticasone/Umeclidin/Vilanter | 606 | 746 | 138 | $462K |
| Albuterol Sulfate Hfa Albuterol Sulfate | 598 | 769 | 212 | $21K |
| Montelukast Sodium Generic | 437 | 882 | 130 | $5,719 |
| Breztri Aerosphere Budesonide/Glycopyr/Formoterol | 409 | 568 | 116 | $348K |
| Prednisone Generic | 273 | 279 | 179 | $581 |
| Azithromycin Generic | 222 | 232 | 126 | $2,679 |
| Roflumilast Generic | 202 | 306 | 49 | $29K |
| Fluticasone Propionate Generic | 167 | 310 | 86 | $2,327 |
| Famotidine Generic | 108 | 186 | 39 | $1,352 |
| Ventolin Hfa Albuterol Sulfate | 83 | 89 | 29 | $5,130 |
| Trazodone Hcl Generic | 80 | 110 | 22 | $449 |
| Anoro Ellipta Umeclidinium Brm/Vilanterol Tr | 69 | 105 | 13 | $47K |
| Zolpidem Tartrate Generic | 64 | 64 | 14 | $206 |
| Fluticasone-Salmeterol Fluticasone Propion/Salmeterol | 61 | 91 | 20 | $13K |
| Eliquis Apixaban | 58 | 71 | 12 | $36K |
Brand drugs: - claims; generic drugs: 2,670 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Salaam T Alobeidy $696 ($696 in general payments such as food, travel and fees) from 6 companies. The largest payer was AstraZeneca Pharmaceuticals LP with $317.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.